Related Articles
ONDANSETRON VERSUS METOCLOPRAMIDE IN THE PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING - A METAANALYSIS
A phase II, randomized study of aprepitant in the prevention of chemotherapy‑induced nausea and vomiting associated with moderately emetogenic chemotherapies in colorectal cancer patients
Difference in the emetic control among highly emetogenic chemotherapy regimens: Implementation for appropriate use of aprepitant
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis
Comparison between the antiemetic effects of palonosetron and granisetron in breast cancer patients treated with anthracycline‑based regimens